Kolexia
Remy Philippe
Neurologie
Hôpital Henri Mondor
Créteil, France
130 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Maladie de Parkinson Glomérulonéphrite lupique Néphrite Inflammation Maladie de Huntington Maladies neuro-inflammatoires Lupus érythémateux disséminé Sclérose en plaques Drépanocytose

Industries

B3TSI
63 collaboration(s)
Dernière en 2023
M3 Global Research Ltd
50 collaboration(s)
Dernière en 2023
P\S\L Group Services
39 collaboration(s)
Dernière en 2023
EXAFIELD
32 collaboration(s)
Dernière en 2023

Dernières activités

LUMA: A Phase 2b, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy and Safety of BIIB122 in Participants With Parkinson's Disease
Essai Clinique (Biogen)   15 mars 2024
Systemic lupus erythematosus associated with HIV infection: a retrospective case-control study.
Clinical and experimental rheumatology   31 janvier 2024
Overview on wearable sensors for the management of Parkinson's disease.
NPJ Parkinson's disease   02 novembre 2023
La maladie de Parkinson : des premiers symptômes aux traitements
France Bleu   01 novembre 2023
Volumetric changes and clinical trajectories in Parkinson's disease: a prospective multicentric study.
Journal of neurology   31 août 2023
Rare Variants in Complement Gene in C3 Glomerulopathy and Immunoglobulin-Mediated Membranoproliferative GN.
Clinical journal of the American Society of Nephrology : CJASN   24 août 2023
Acute ataxia induced by nitrous oxide abuse in young adults during the COVID-19 pandemic.
Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias   26 juin 2023
FDPA-714: Effect of co-medications, age, sex, BMI and TSPO polymorphism on the human plasma input function.
European journal of nuclear medicine and molecular imaging   09 juin 2023
PIMPARK: Study of Pimavanserin Efficacy for the Treatment of Impulse Control Disorders in Parkinson's Disease
Essai Clinique (CHU Strasbourg)   09 mai 2023
BUSPARK: Buspirone Treatment of Iatrogenic Dyskinesias in Advanced Parkinson' Disease. Multicenter, International, Placebo-controlled, Randomised, Double Blind Trial
Essai Clinique (Assistance publique – Hôpitaux de Paris)   11 avril 2023